Innovation
19 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 717 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 3 |
Social engagement
Social engagement: 1.8K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Cenova, Canaan, 6 Dimensions Capital, Boxer Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Other / undisclosed | 2 | 22% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
5 Jun 2026 · Senior Director, Clinical Pharmacology/ADME/DMPK
11 Aug 2025 · Executive Director of Clinical Development
Based on job postings tracked across public sources.
Recent activity
9 Oct 2025
Event
ESMO Congress 2025
8 Oct 2025
Milestone
regulatory